Kybella commonly causes swelling, bruising, pain, numbness, redness, and firmness under the chin. Those reactions are expected and usually improve with time, although some can last longer than patients anticipate. Less common but more important risks include marginal mandibular nerve injury that can cause an uneven smile, difficulty swallowing, infection, ulceration, skin necrosis, vascular injury, hair loss at the injection site, and persistent nodules or masses. In September 2026, the FDA added stronger warnings about nodules and masses that may not resolve and about serious adverse reactions when deoxycholic acid is used outside the approved submental area.
Key Takeaways
- Swelling is the most common Kybella reaction and can be visually significant.
- Bruising, pain, numbness, redness, and firmness are also common after treatment.
- Nerve injury can cause facial weakness or an uneven smile, while dysphagia can cause swallowing difficulty.
- Skin ulceration, necrosis, infection, vascular injury, hair loss, and persistent nodules or masses are recognized complications.
- Kybella is FDA approved for submental fat in adults. The FDA now recommends against use outside the submental region because serious adverse events have been reported.
What are the most common Kybella side effects?
Kybella contains deoxycholic acid, a cytolytic drug that disrupts fat-cell membranes. The resulting local tissue response explains why swelling, tenderness, and firmness are so common after injection.
In the pooled registration trials described in the Kybella prescribing information, 96% of treated subjects reported at least one injection-site reaction.
| Reaction | Rate in pooled Kybella trials | What patients may notice |
|---|---|---|
| Swelling or edema | 87% | Temporary fullness beneath the chin |
| Bruising or hematoma | 72% | Discoloration or localized collection of blood |
| Pain | 70% | Soreness, burning, or tenderness |
| Numbness | 66% | Reduced sensation in the treated area |
| Redness | 27% | Localized erythema |
| Firmness or induration | 23% | Hard or firm-feeling treatment areas |
| Tingling or paresthesia | 14% | Altered sensation |
| Nodule | 13% | Localized palpable lump |
Those percentages come from clinical trials in adults with moderate to severe submental fullness and should not be treated as a prediction for one individual patient.
How long does Kybella swelling last?
Visible swelling is often most noticeable during the first several days, but the prescribing information shows that some reactions can last considerably longer.
In the pooled trials, injection-site numbness, swelling, pain, and induration lasted more than 30 days in a subset of patients. Specifically, prolonged numbness occurred in 42% of treated subjects, prolonged swelling in 20%, prolonged pain in 16%, and prolonged firmness in 13%.
This is why describing Kybella as having “no downtime” can be misleading. It does not require surgical recovery, but patients may have repeated periods of visible swelling if several sessions are planned.
The Adonis Kybella swelling timeline explains the usual progression from early swelling to later contour assessment in more detail.
Can Kybella cause nerve damage?
Yes. The prescribing information warns about marginal mandibular nerve injury.
This nerve helps control movement of the lower lip. Injury can cause facial muscle weakness or an asymmetric smile. In the pooled clinical trials, nerve injury identified as marginal mandibular nerve paresis was reported in 4% of Kybella-treated subjects.
The main safety issue is anatomy. The provider must identify the intended submental treatment zone and avoid injecting too close to vulnerable structures.
Patients who notice new lower-lip weakness or an uneven smile after treatment should contact the treating clinician rather than assuming it is ordinary swelling.
Can Kybella make it difficult to swallow?
Yes. Dysphagia, or difficulty swallowing, is a recognized warning in the prescribing information.
In the pooled trials, dysphagia was reported in 2% of Kybella-treated subjects. Reported cases resolved spontaneously, with a median duration of three days and a range from one to 81 days.
The label advises avoiding Kybella in patients with a current or prior history of dysphagia because treatment may worsen the condition.
New swallowing difficulty should be reported promptly, particularly if it is worsening or affecting the ability to eat, drink, or handle secretions.
Can Kybella cause lumps or nodules?
Yes, and this issue became more important in the 2026 FDA label update.
On September 15, 2026, the FDA announced additional Kybella safety labeling after reviewing adverse-event reports and medical literature. The agency identified an association between deoxycholic acid and injection-site nodules or masses.
FDA identified 117 reported cases of unresolved nodules or masses. At the time they were reported, the average duration was approximately five months. Some required medical intervention.
This does not mean every firm area after Kybella is a serious complication. Early firmness is common. What matters is persistence, size, pain, inflammation, and whether the area is changing over time.
Can Kybella damage the skin?
Yes. Injection-site ulceration, necrosis, and infection are recognized complications.
The prescribing information warns that injections placed too superficially into the dermis can cause ulceration and tissue necrosis. Postmarketing reports have also included cellulitis and abscesses requiring intravenous antibiotics or incision and drainage.
Increasing redness, drainage, open sores, progressive pain, or skin breakdown after treatment should be assessed promptly.
Can Kybella injure a blood vessel?
It can if the drug is inadvertently injected into an artery or vein.
The prescribing information specifically warns clinicians to avoid intravascular injection because vascular injury can occur. It also advises avoiding injection into or too close to salivary glands, lymph nodes, and muscles.
Kybella is therefore not simply “fat-dissolving liquid.” It is a prescription injectable that must be placed in the correct anatomical layer and treatment zone.
Can Kybella cause hair loss?
Yes. Injection-site alopecia has been reported.
The prescribing information notes that onset and duration vary and that hair loss can persist. It recommends considering withholding additional treatment until the reaction resolves.
This complication is less commonly discussed than swelling or numbness, but it belongs in informed consent because it can be cosmetically important in the submental and beard area.
What changed in the FDA Kybella warning in September 2026?
The FDA added two important areas of safety information.
First, the agency strengthened labeling around injection-site nodules and masses, including cases that did not resolve and sometimes required medical treatment.
Second, FDA added a warning about serious adverse events associated with injecting deoxycholic acid outside the submental region. Kybella is approved for improvement in moderate to severe submental fullness in adults. It is not approved for routine fat reduction on other areas of the face or body.
The FDA identified 129 adverse-event cases involving deoxycholic acid used outside the approved submental site. Reported problems included blurred or reduced vision, involuntary eye contractions, facial weakness, paresthesia, muscle or nerve injury, and difficulty walking.
Current FDA position: Kybella is not approved for fat reduction outside the submental area, and the FDA recommends against such unapproved use because serious adverse events have been reported.
Is Kybella safer because it is nonsurgical?
Nonsurgical does not mean risk-free.
Kybella avoids incisions, operative liposuction, and surgical anesthesia, but it introduces an injection-specific risk profile that includes nerve injury, swallowing difficulty, tissue injury, vascular injury, persistent nodules, and repeated inflammatory swelling.
Chin liposuction has a different set of risks, including bleeding, infection, seroma, contour irregularity, scarring, anesthesia-related complications, and injury to nearby structures.
The Adonis comparison of Kybella versus chin liposuction explains why the choice should be based on anatomy, skin elasticity, amount of fat, recovery preferences, and risk tolerance rather than simply “surgical” versus “nonsurgical.”
Who may not be a good candidate for Kybella?
Kybella is contraindicated when there is an active infection at the injection site.
The prescribing information also advises careful evaluation when patients have excessive skin laxity, prominent platysmal bands, previous surgery or aesthetic treatment in the submental area, bleeding abnormalities, anticoagulant or antiplatelet therapy, or a history of swallowing problems.
This matters because submental fullness is not always caused by superficial fat. Loose skin, platysma, deep fat, salivary glands, chin projection, and other neck structures can create a similar profile.
If skin laxity is significant, reducing fat may expose or worsen the appearance of loose skin rather than creating a sharper jawline.
When is Kybella a better fit than chin liposuction?
Kybella can be a reasonable option when the concern is truly localized submental fat, skin quality is appropriate, the patient wants to avoid surgery, and repeated treatment sessions and swelling are acceptable.
Chin liposuction may make more sense when a larger amount of accessible submental fat needs direct removal in one surgical procedure.
The Adonis chin liposuction page explains how fat location, skin elasticity, jaw structure, and deeper neck anatomy determine whether liposuction is appropriate.
For patients considering Kybella itself, the Skin Works Medical Spa Kybella guide outlines candidacy, expected swelling, treatment planning, and how skin quality is assessed before recommending injections.
What if the main problem is loose skin, not fat?
Kybella is a fat-reduction treatment, not a skin-removal procedure.
If the visible problem is mostly lax skin or platysma bands, removing submental fat may not solve the concern. In some cases it can make loose skin more apparent because there is less volume beneath it.
The Adonis article on treating sagging neck skin compares neck lift, facelift, ultrasound, radiofrequency, Botox, liposuction, and resurfacing according to the anatomical cause of the neck contour.
What symptoms should you report after Kybella?
Contact the treating clinician for new facial weakness, an uneven smile, difficulty swallowing, persistent or worsening pain, unusual swelling, open sores, drainage, significant redness, skin breakdown, or a persistent lump or mass.
Serious or progressive symptoms should not be managed solely with home aftercare advice.
Patients should also report any unexpected neurologic, visual, or muscle symptoms, especially if deoxycholic acid was injected outside the approved under-chin area.
How should you judge whether Kybella risk is worth it?
Start by confirming that the problem is actually submental fat.
Then ask how many sessions are realistically expected, how visible the swelling may be, whether skin laxity is likely to limit the result, and whether a one-time surgical approach would better match the anatomy.
Also ask about the exact injection area, provider experience with submental anatomy, how complications are handled, and whether any proposed use is outside the FDA-approved submental indication.
A minimally invasive treatment should still have a clear indication, clear limits, and a clear complication plan.
Honest limitation: clinical-trial percentages describe selected study populations and may not predict one patient's experience. Postmarketing reports can reveal rare complications but cannot reliably establish how often they occur because events are reported voluntarily and the total number of exposed patients is unknown.
Frequently Asked Questions
What is the most common side effect of Kybella?
Swelling is the most common reaction. In pooled clinical trials, injection-site swelling occurred in 87% of Kybella-treated subjects. Bruising, pain, numbness, redness, and firmness were also common. Visible swelling can be substantial even though Kybella does not require surgical recovery.
Can Kybella cause permanent nerve damage?
Kybella can injure the marginal mandibular nerve and cause an uneven smile or facial weakness. Most reported trial cases were temporary, but any new lower-lip weakness should be evaluated. Proper anatomy, treatment-zone selection, and injection technique are important risk-reduction measures.
How long can Kybella numbness last?
Numbness is common and can last longer than visible swelling. In the registration trials, 42% of treated subjects experienced injection-site numbness lasting more than 30 days. Persistent or unusual sensory changes should still be discussed with the treating provider.
Can Kybella cause lumps that do not go away?
Yes. In September 2026, FDA added stronger warnings after identifying reports of persistent injection-site nodules and masses. Some remained unresolved for months and required medical intervention. A persistent or enlarging lump should be evaluated rather than assumed to be routine firmness.
Can Kybella be used on belly fat or other body areas?
Kybella is FDA approved for submental fat in adults, not for routine fat reduction on other body areas. In September 2026, FDA added warnings about serious adverse events from use outside the submental region and recommended against that unapproved use.
Is Kybella safer than chin liposuction?
Neither is universally safer. Kybella avoids surgery but has injection-specific risks such as nerve injury, swallowing difficulty, prolonged swelling, tissue injury, and nodules. Chin liposuction has surgical and anesthesia-related risks. The better choice depends on anatomy, fat volume, skin elasticity, and individual risk factors.
Make sure the problem is fat before choosing the injection
The surgical team at Adonis Plastic Surgery can evaluate submental fat, skin laxity, platysma, chin projection, and neck anatomy and explain whether Kybella, chin liposuction, or another approach better matches the contour problem and the amount of correction you want.
Request a ConsultationReferences
Adonis Plastic Surgery is located at 2557 Pacific Coast Highway in Torrance, California, serving patients across the South Bay including Redondo Beach, Palos Verdes Estates, Manhattan Beach, San Pedro, Long Beach, El Segundo, Carson and Gardena.
